DRIVING DRUG DISCOVERY THROUGH STRUCTURE

Biodesy discovers novel therapeutic molecules for difficult-to-drug targets by leveraging its proprietary, structure-driven platform. By combining knowledge about a drug target’s native biology with our novel technology for directly measuring structural changes, we can efficiently identify molecules that induce functionally relevant structural changes in difficult-to-drug targets.

News

Biodesy Announces New CEO and $20 Million Series C Financing to Accelerate Expansion into Biotherapeutics Discovery and Development Market

September 10, 2018

Biodesy Delta System Enables Researchers to Discover Novel Mechanism Involved in Infectious Disease

November 20, 2017

Events

Drug Discovery Chemistry 2019

April 9-April 11, 2019 San Diego Convention Center, San Diego, CA

Presenting at Fragment-based Lead Discovery Conference (FBLD) 2018

October 7-October 10, 2018 San Diego, USA